|
Pronunciation |
|
(eye
soe SOR
bide) |
|
|
U.S. Brand
Names |
|
Ismotic® |
|
|
Generic
Available |
|
No |
|
|
Pharmacological Index |
|
Diuretic, Osmotic; Ophthalmic Agent, Antiglaucoma; Ophthalmic Agent,
Osmotic |
|
|
Use |
|
Short-term emergency treatment of acute angle-closure glaucoma and short-term
reduction of intraocular pressure prior to and following intraocular surgery;
may be used to interrupt an acute glaucoma attack; preferred agent when need to
avoid nausea and vomiting |
|
|
Pregnancy Risk
Factor |
|
B |
|
|
Contraindications |
|
Severe renal disease, anuria, severe dehydration, acute pulmonary edema,
severe cardiac decompensation, known hypersensitivity to
isosorbide |
|
|
Warnings/Precautions |
|
Use with caution in patients with impending pulmonary edema and in the
elderly due to the elderly's predisposition to dehydration and the fact that
they frequently have concomitant diseases which may be aggravated by the use of
isosorbide; hypernatremia and dehydration may begin to occur after 72 hours of
continuous administration. Maintain fluid/electrolyte balance with multiple
doses; monitor urinary output; if urinary output declines, need to review
clinical status. |
|
|
Adverse
Reactions |
|
1% to 10%:
Central nervous system: Headache, confusion, disorientation
Gastrointestinal: Vomiting
<1%: Syncope, lethargy, vertigo, dizziness, lightheadedness, irritability,
rash, hypernatremia, hyperosmolarity, nausea, abdominal/gastric discomfort
(infrequently), anorexia, hiccups, thirst |
|
|
Overdosage/Toxicology |
|
Symptoms of overdose include dehydration, hypotension, hyponatremia
General supportive care, fluid administration, electrolyte balance,
discontinue agent |
|
|
Drug
Interactions |
|
No data reported |
|
|
Mechanism of
Action |
|
Elevates osmolarity of glomerular filtrate to hinder the tubular resorption
of water and increase excretion of sodium and chloride to result in diuresis;
creates an osmotic gradient between plasma and ocular
fluids |
|
|
Pharmacodynamics/Kinetics |
|
Onset of action: Within 10-30 minutes
Peak action: 1-1.5 hours
Duration: 5-6 hours
Distribution: In total body water
Metabolism: Not metabolized
Half-life: 5-9.5 hours
Elimination: By glomerular filtration; see Mechanism of Action
|
|
|
Usual Dosage |
|
Adults: Oral: Initial: 1.5 g/kg with a usual range of 1-3 g/kg 2-4 times/day
as needed |
|
|
Monitoring
Parameters |
|
Monitor for signs of dehydration, blood pressure, renal output, intraocular
pressure reduction |
|
|
Mental Health: Effects
on Mental Status |
|
May cause confusion or disorientation; may rarely cause drowsiness,
dizziness, or irritability |
|
|
Mental Health:
Effects on Psychiatric
Treatment |
|
None reported |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
This is for short-term treatment, it is not for long-term use. Pour over
cracked ice and sip. Take all of medication. You may experience frequent
urination (maintain adequate hydration); gastric upset (small frequent meals may
help); dizziness, drowsiness, or confusion (use caution when driving); or dry
mouth (chewing gum, frequent oral care, sucking on lozenges may help). Report
difficulty breathing, unrelieved headache, changes in CNS (eg, confusion or
disorientation). Consult prescriber if breast-feeding. |
|
|
Nursing
Implications |
|
Palatability may be improved if poured over ice and
sipped |
|
|
Dosage Forms |
|
Solution: 45% [450 mg/mL] (220
mL) |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|